Tradestie Institutional Equity Comparison Engine
CRSP vs ACAD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACAD Overall Edge
ACAD Captures Institutional Edge (4โ0 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Pharmaceuticals Inc. (ACAD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CRSP trades at 23.4x Forward P/E with -2058.6% operating margin (+1325.1% YoY revenue) versus ACAD at 17.8x Forward P/E and 10.2% operating margin (+22.8% YoY). In options structure, CRSP sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against ACAD sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ACAD
CRSP 23.4x vs ACAD 17.8x Fwd P/E
Growth & Margin Winner
ACAD
Op Margin -2058.6% vs 10.2% ยท YoY +1325.1% vs +22.8%
Momentum & Technical Winner
ACAD
1Y -20.5% vs -19.3% ยท 52W Pos 1% vs 21%
Options & Structure Winner
ACAD
BREAKDOWN (52nd %ile IV) vs BREAKDOWN (4th %ile IV)
CRSP
NASDAQ
CRISPR Therapeutics AG
Biological Products, (No Disgnostic Substances)
$40.61
-3.86% 1D
Market Cap
$4.1B
1M Return
-17.54%
1Y Return
-20.54%
Forward P/E
23.4x
Unified AI Score
48.6 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 68.0
Mom 60.0
ACAD
NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$19.07
+1.71% 1D
Market Cap
$3.1B
1M Return
-0.26%
1Y Return
-19.33%
Forward P/E
17.8x
Unified AI Score
46.7 / 100
HOLD
Tech 41.0
Fund 52.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CRSP -20.54%
ACAD -19.33%
Spread: +1.21 pp (ACAD Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CRSP Revenue | ACAD Revenue | CRSP Op. Margin | ACAD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $220M | -5087.8% | -110.6% | ACAD |
| FY2019 | $290M | $340M | 16.1% | -72.7% | CRSP |
| FY2020 | $0M | $440M | -49295.5% | -64.9% | ACAD |
| FY2021 | $910M | $480M | 40.8% | -35.2% | CRSP |
| FY2022 | $0M | $520M | -56190.4% | -43.2% | ACAD |
| FY2023 | $370M | $730M | -60.0% | -10.1% | ACAD |
| FY2024 | $40M | $960M | -1250.4% | 24.1% | ACAD |
| FY2025 | $0M | $1.07B | -18933.6% | 9.8% | ACAD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CRSP | ACAD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.1B | $3.1B | Larger Scale | CRSP |
| Trailing P/E Ratio Valuation | 23.4x | 8.6x | Lower Multiple | ACAD |
| Forward P/E Ratio Valuation | 23.4x | 17.8x | Lower Multiple | ACAD |
| Revenue Growth (YoY) Growth | +1325.1% | +22.8% | Higher Growth | CRSP |
| Operating Margin (TTM) Profitability | -2058.6% | 10.2% | Higher Margin | ACAD |
| Net Profit Margin Profitability | 0.0% | 30.1% | Higher Margin | ACAD |
| Return on Equity (ROE) Capital Efficiency | -25.6% | 31.4% | Higher ROE | ACAD |
| 52-Week Range Position Momentum | 1% ($40โ$63) | 21% ($16โ$31) | Stronger Trend | ACAD |
| Beta / 30D Volatility Risk Regime | 1.85ฮฒ ยท 60% Vol | 0.11ฮฒ ยท 93% Vol | Lower Realized Risk | CRSP |
| Unified Institutional Score Composite Signal | 48.6 / 100 (HOLD) | 46.7 / 100 (HOLD) | Higher Composite | CRSP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CRSP vs ACAD Buy Guide
CRSP
BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
52nd %ile
IV Regime
Balanced (25thโ60th %ile)
ACAD
BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CRSP nor ACAD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.